Front Endocrinol (Lausanne)
June 2022
BRAF mutation is a representative oncogenic mutation, with a frequency of 60% in papillary thyroid carcinoma (PTC), but the reasons for the poor prognosis and more aggressive course of BRAF-mutated PTC are controversial. Tumor immune microenvironment (TIME) is an essential factor permitting the development and progression of malignancy, but whether TIME participates in the prognosis of BRAF-mutated PTC has not yet been reported. The primary goal of the present study was to provide a comprehensive TIME-related prognostic model to increase the predictive accuracy of progression-free survival (PFS) in patients with BRAF-mutated PTC.
View Article and Find Full Text PDFGraves' ophthalmopathy (GO) has become one of the most common orbital diseases. Although some evidences announced the potential mechanism of pathological changes in extraocular muscle and orbital adipose tissue, little is known about that in lacrimal enlargement of GO patients. Thus, gene expression profiles of lacrimal gland derived from GO patients and normal controls were investigated using the microarray datasets of GSE105149 and GSE58331.
View Article and Find Full Text PDFis undoubtedly one of the most clinically significant pathogens. The multidrug resistance and virulence potential of are responsible for hospital-acquired nosocomial infections. Unlike numerous investigations on the drug-resistant epidemiology of , virulence molecular epidemiology is less studied.
View Article and Find Full Text PDF